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Understanding mutational effects on protein stability and
solubility is of particular importance for creating industrially
relevant biocatalysts, resolving mechanisms of many human
diseases, and producing efficient biopharmaceuticals, to name a
few. For in silico predictions, the complexity of the underlying
processes and increasing computational capabilities favor the
use of machine learning. However, this approach requires
sufficient training data of reasonable quality for making precise
predictions. This minireview aims to summarize and scrutinize
available mutational datasets commonly used for training
predictors. We analyze their structure and discuss the possible
directions of improvement in terms of data size, quality, and
availability. We also present perspectives on the development
of mutational data for accelerating the design of efficient
predictors, introducing two new manually curated databases
FireProtDB and SoluProtMutDB for protein stability and solubility,
respectively.
1. Introduction
Efficient design of stable and soluble protein variants is one of
the principal goals of biocatalyst engineering. Understanding
the mechanisms governing protein stability and solubility
changes upon mutations is of paramount importance in several
domains, including biotechnology, medicine, and
biopharmaceutics.[1,2] Biocatalyst production suffers losses from
time and resources wasted on poorly soluble and unstable
protein mutants,[3] and in industrial applications, improved
stability against harsh environments often becomes critical.[4]
Improving properties of valuable but difficult-to-work-with
proteins that have borderline stability or are poorly soluble
outside living cells presents another major challenge in
biotechnology.[5,6] Moreover, human neurodegenerative disor-
ders, metabolic diseases, and cancer are often linked to
mutations leading to protein misfolding, aggregation,[7–9] or
decreased solubility,[10,11] and unstable or insoluble proteins may
lead to precipitates triggering an unwanted immune response
in patients.[12]
Given the astoundingly vast protein sequence space to
explore in the pursuit of improved stability and solubility,
computational tools are used increasingly to narrow down the
search to ideally only a few promising mutations to be tested
experimentally.[1] Many recent successes in designing improved
variants relied on incorporating in silico prediction in the
pipeline,[13,14] e. g. in the recent application of computer-assisted
protein engineering strategy to modify fibroblast growth
factor[15] to yield unprecedented stability and uncompromised
biological function (Figure 1). Several new reviews provide
excellent overviews of modern approaches and success stories
in applying computational methods for engineering stable and
soluble biocatalysts.[16–20]
Computational tools often rely on a set of rationally chosen
rules applied at different steps of the protein engineering
workflow. Many factors may potentially affect the outcome of
introducing mutations: from physico-chemical properties of
substitutions locally[21] to global changes in the protein
backbone.[22] Composite combinations of those factors have
also been reported to lead to better design capabilities, e.g.
protein spectra derived by digital signal processing was shown
to be useful in the design of stereoselectivity.[23,24] This complex-
ity promotes the use of machine learning (ML) techniques, i. e.
general-purpose algorithms for automatic rule generation
based on patterns in available data.[25] Such algorithms have
already substantially advanced our capabilities in image analy-
sis, speech recognition, natural language processing, and other
intrinsically complex tasks.[26,27] Therefore, their application to
such sophisticated problems as predicting mutational effects on
protein stability and solubility was only a matter of time.
Many promising ML-based predictors have been published
for either task.[1,28–30] However, they all seem to be testing a
similar limit to the prediction accuracy, e.g. the root mean
square error of around 1 kcal/mol for stability predictions.[1]
Moreover, independent experimental validation in subsequent
studies often reveals modest performance.[28,31–33] Several ex-
planations can be provided, one of which is the limited data
size and quality available for training: data quality and
abundance are critical for ML algorithms as they ultimately aim
to identify and generalize patterns in the training data.
In this minireview, we focus on the databases and data sets
habitually used to train such predictors. We briefly discuss their
structure and associated challenges, from misleading notations
and erroneous entries to the problem of aggregating results
from different experimental setups. We conclude with the
perspectives in improving those sets with the hope that it will
further accelerate the usage of modern data analysis ap-
proaches to uncover the driving forces behind the effects in
question.
We chose to consider both stability and solubility muta-
tional data due to the similar structure of data as well as
intertwined effects of the underlying mechanisms. On the one
hand, unstable proteins tend to aggregate and are prone to
faster degradation by proteolysis,[34] producing a negative signal
in solubility assays. On the other hand, protein stabilization
achieved by means of protein engineering was often reported
to come at the cost of reducing protein solubility.[17,28] For
instance, stabilization strategies frequently suggest surface
mutations that increase hydrophobicity, and while such muta-
[a] Dr. S. Mazurenko
Loschmidt Laboratories




601 77 Brno (Czech Republic)
E-mail: mazurenko@mail.muni.cz
This publication is part of a Special Collection on “Data Science in Catalysis”
Please check the ChemCatChem homepage for more articles in the col-
lection.
© 2020 The Authors. Published by Wiley-VCH GmbH. This is an open access
article under the terms of the Creative Commons Attribution License, which
permits use, distribution and reproduction in any medium, provided the




5591ChemCatChem 2020, 12, 5590–5598 www.chemcatchem.org © 2020 The Authors. Published by Wiley-VCH GmbH
Wiley VCH Mittwoch, 11.11.2020


























































tions do often increase stability,[35] they tend to have a
detrimental effect on solubility. The flexibilities of side chains
and whole protein regions have been reported to guide the
engineering of both stability[36] and solubility.[37] Moreover, the
structure of mutational datasets for these two tasks is quite
similar. The joint focus on both problems is, therefore, expected
to bring benefit to the communities working on either task.
2. Data for training protein stability predictors
Recent developments in X-ray crystallography, NMR, cryo-
electron microscopy allow solving protein structures at Ang-
strom and even sub Angstrom resolution[38] revealing the
structural basis of protein binding, catalysis, and stability at the
level of individual amino acids. However, such experiments are
expensive, low throughput, require sophisticated instrumenta-
tion, and are often limited by the protein size. Therefore, most
data on protein stability changes upon mutation come from
less demanding techniques, namely differential scanning calo-
rimetry, light scattering, circular dichroism, fluorescence spec-
troscopy, etc.[39] In those experiments, protein in solution is
denatured by physical (temperature, pressure), chemical (pH,
osmolytes), or biological (proteases) perturbation, and the
output signal is recorded and analyzed. For temperature
denaturation, this analysis typically yields the melting temper-
ature Tm, loosely defined as the apparent midpoint of the
transition in the signal, the difference in Gibbs free energy of
the unfolded and folded states ~G, typically derived from data
fitting, or the activity-related temperature T50 at which the
residual activity is reduced by 50% after incubation.
The pioneering effort in collecting mutational stability data
from literature resulted in ProTherm,[40–42] a comprehensive
database comprising numerical data from protein denaturation
experiments, structural information, description of experimental
methods and conditions. The overwhelming majority of protein
stability change predictors were trained on the data from this
database.[1] In Table 1, we summarize the most commonly used
derivatives of ProTherm as well as recent additions. Unfortu-
nately, the database was last updated in 2013 and has not been
actively maintained since then. This resulted in many outdated,
imprecise, or erroneous entries, which necessitated substantial
manual data cleaning. Among major issues unidentified by the
teams working on stability predictions[43–46] were nonmatching
protein sequences and PDB entries, wrong signs and units of
reported values, data incompatibility due to a wide range of
experimental conditions, lack of representation for some
substitutions, inadequate disclosure in the source papers. Many
reported ~Tm and ~~G values were determined under the
assumption of a simple one-step reversible denaturation,
whereas many proteins undergo multi-step denaturation that is
not evident without proper data analysis.[47,48] The occasional
presence of heat capacity difference of unfolding ~Cp introdu-
ces a temperature dependence to ~G,[49] rendering the latter
values accurate only in a narrow temperature range of the
transition. However, the values reported were sometimes
extrapolated to the room temperature or Tm of the wild type.
Several tendencies can be identified based on Table 1. All
the datasets are restricted to single-point mutants, and in most
of them only those with available PDB structure are preserved.
Multiple values are averaged, and extreme conditions are
sometimes excluded, as well as extreme values due to higher
expected measurement errors and more significant changes to
the structure of wild types upon introducing mutations. Only
several teams performed a manual cleanup of the data and
revealed massive inconsistencies in reported values, parameters,
and structures. Moreover, data preprocessing in general varies
significantly. This supports our hypothesis that the limited data
size and quality might be the reason for a modest performance
of ML-based predictors in independent tests.
Regarding the data structure, the wild type proteins are
uniformly distributed among the four major SCOP structural
classifications, as observed in S1948.[50] The authors of S1564[43]
identified that the largest numbers of variants are for lysozyme
(16%), followed by barnase (8%) and gene V protein (7%);
most common are substitutions for alanine (26%) and sub-
stitutions from valine (11%); the least frequent are substitutions
from tryptophan (only 18 out of 1564), and some substitutions
are not represented at all. In each dataset, most mutations are
destabilizing, and this imbalance may affect negatively the
performance of the resulting predictor. Indeed, many predictors
were reported to demonstrate a similar bias: mutations are
usually correctly predicted as destabilizing, but those predicted
stabilizing on average turn out to be neutral during exper-
imental validation.[28]
Apart from ProTherm data, some predictors were tested on
42 mutations of the DNA binding domain of the tumor
suppressor protein p53,[60] and the performance of several
predictors was recently evaluated on two newly collected
datasets: 96 single-point mutants of guanylate kinase[61] and 51
mutants of β-glucosidase.[33] Several teams performed an addi-
tional independent literature search, revealing the promising
prospects of seeing improved protein stability predictors in the
near future. Many data sets from Table 1 can also be found in
VariBench – a platform for sharing published variation data for
benchmarking.[58,59] Augmenting the datasets with reverse
mutations with opposite signs of ΔΔG or ΔTm has also gained
attention recently to promote the so-called anti-symmetry of
predictors: reverse mutations should produce the same pre-
dictions but with opposite signs, which turns out not to be the
case for many predictors.[31,32] To provide the community with
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additional high quality data, we have manually processed the
data from ProTherm as well as new data from literature and are
depositing them to our database FireProtDB, where they can be
accessed via a user-friendly graphical interface (Figure 2). We
expect to release the databased in the next few months, and its
landing page can be found at loschmidt.chemi.muni.cz/fire-
protdb.
3. Data for training protein solubility predictors
Mutational datasets for protein solubility are much more scant
and heterogeneous. Protein solubility is typically defined as the
concentration of folded protein in a saturated solution when in
equilibrium with the solid phase. This quantity is usually
estimated in vitro by increasing protein concentration, e.g. by
adding lyophilized protein to the solvent or by protein ultra-
filtration with subsequent estimating of protein fractions in the
supernatant and the pellet, sometimes with the aid of various
precipitants such as salts, organic solvents, or long-chain
polymers.[62] At the same time, solubility can be defined more
generally as in vivo expression, which is usually estimated as
expression yield or its proxy, e.g. fluorescence intensity in split-
GFP systems[63] or luminescence in split-NaNoLuc assays.[64]
Protein expressibility depends on many factors as many
components of a cell are involved in its synthesis and folding
Figure 1. The integrated strategy combining computational analyzes with focused directed evolution for engineering the hyperstable fibroblast growth factor
FGF2. Several in silico and in vitro steps resulted in the third generation protein FGF-G3 with ~Tm of 19 °C. Reproduced with permission from Dvorak and co-
workers.[15] Copyright 2018, John Wiley and Sons.
Figure 2. The graphical user interface of FireProtDB (loschmidt.chemi.muni.cz/fireprotdb) containing manually curated thermostability data. The analogous web
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pathways; and any perturbation of those pathways affects the
solubility.
Early attempts to collect solubility data systematically at the
scales suitable for general ML were made towards full
sequences. In 2009, a collaborative effort of the Targeted
Proteins Research Project resulted in eSoL database that
comprises solubility data of around 4000 Escherichia coli
proteins measured using the PURE cell-free expression
system.[65] The more prolonged Protein Structure Initiative
resulted in the TargetTrack database with more than 300 000
protein expressed and annotated.[66] Although aimed at a large-
scale structure determination, it provides a proxy for quantifica-
tion of protein solubility based on expressibility. The major
limitation of the two databases in our context is the absence of
mutational data. While some studies demonstrated potential in
predicting mutational effects on solubility after training on wild
Table 1. Mutational datasets for training protein stability predictors derived from the ProTherm database.











58/55 Only single-point mutations accompanied by experimental pH, temperature, and
structures at atomic resolution were considered. In S1925, 12 mutants for two
proteins whose structures had missing residues, one trivial mutation, and 10











131/67 Only single-point mutations in globular proteins with available X-ray or NMR
structure were considered. Mutations in pseudo wild types and hemeproteins, those
destabilizing the structure by more than 5 kcal/mol, and those involving proline
were removed due to significant expected structural modifications. Multiple ΔΔG
values were weighted-averaged, preferring pH close to 7, a temperature close to










60 Only single-point mutations in proteins with available PDB structures were
considered. The authors used Profix to fix structural defects (missing atoms, residues,
or gaps), and TINKER for energy minimization, removing the proteins that failed to
be processed by either tool. Only the data measured for pH 6–8 were considered










95 A manually corrected subset that contains only single-point mutants. Multiple ΔΔG
values for the same experimental conditions were averaged; for different
experimental conditions, only the value closest to pH 7 was kept. Seventy four
clusters of proteins with more than 25% sequence similarity using BLASTCLUST
were identified. For several measurements of the same amino acid substitution
within a single cluster, only the measurement closest to pH 7 was kept.
csv file on the
web server[c]
2014




51 Only single-point mutations in proteins with available PDB structures were
considered. Only the data measured for pH 6–8 were kept. Mutations were selected
only in small and medium monomeric proteins with no more than 300 residues.
Multiple ΔΔG values for the same experimental conditions were averaged.
Mutations with the absolute ΔΔG >10 kcal/mol were removed due to higher
expected errors.
xlsx table 2015




90 A manually corrected subset of ~Tm data from ProTherm and literature search. Only
single-point mutations in proteins with X-ray structures with the resolution of
<2.5 Å were considered. Only mutations characterized in monomeric proteins
undergoing a two-state unfolding transition were included. Those with absolute
ΔTm of more than 20 °C were removed due to significant expected structural
modifications. Multiple ΔTm values for the same experimental conditions were
averaged; for different experimental conditions, only the value closest to pH 7 and
with the lowest concentration of additives was kept. Other thermodynamic









32 Only single-point mutants with PDB IDs for wild type proteins that have a sequence













49/42 Only single-point mutations in proteins with available PDB structures were
considered. Only the data measured for pH 5–9 were kept. Multiple ΔΔG values
with the variation <0.1 kcal/mol were averaged. The tDB subset consists of cases
with X-ray structures with no ligands.
Dataset 15 2016




99 A manually corrected subset of single-point mutants. The cases with ~G values
between   0.5 and 0.5 kcal/mol are considered neutral. No chain IDs are given, and
131 entries for 20 proteins lack PDB IDs.
Dataset 5 2018




242/37 A manually corrected subset of ProTherm and literature search. Only single-point
mutations in proteins with available structures were considered. The smaller subset
consists of proteins with sequence identity �25% to proteins in S2648 and the
larger set.
xlsx table 2019
[a] Stab. – stabilizing, neut. – neutral (zero change if not indicated otherwise), dest. – destabilizing. [b] Dataset numbers are given as per structure.bmc.lu.se/
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type sequences only,[67] the major effort in the area was focused
on assembling mutational data from existing literature (Table 2),
similar to the datasets used for training protein stability
predictors, and training an ML-based predictor on those data-
sets even despite the modest data size.
Regarding their structure, these datasets show only slight
imbalance, except for CamSol dataset with just three mutations
decreasing solubility. They were compiled from multiple
independent publications, and the different scales for classify-
ing solubility changes reveal that considerable effort is required
to make the values compatible. In the largest data set PonSol,
the number of mutants per protein ranges from 52 for
Interleukin-1β to below 3 for a dozen proteins. The most
common are substitutions for alanine (16%) and substitutions
from leucine (11%) and lysine (10%); approximately half of the
possible substitution pairs are not represented at all. A
significant overlap in the data among different sets can be
observed, which hinders a proper comparison of ML predictors
trained on different sets. This indicates that the community will
benefit significantly from a curated database resolving the
overlaps as well as absorbing data published more recently. To
address this limitation, we are currently working on the
manually curated database SoluProtMutDB (loschmidt.chemi.mu-
ni.cz/soluprotmutdb) that will comprise both the data system-
atically collected from published sources and the experimental
data collected in our laboratory.
4. Perspectives
The analysis of the literature presented in this study demon-
strates how challenging the task of collecting mutational data is
even for such habitually measured protein properties as stability
and solubility. Apart from data scarcity, which is arguably most
urgent in the latter case, the data quality requires much
attention. This problem comes in different flavors: from
inaccuracies, insufficient disclosure, and lack of standard
protocols of data analysis in the original publications, to the
errors and difficulties of aggregating information from different
sources, biases and imbalances in the resulting datasets. There-
fore, the community of researchers developing ML predictors of
protein stability and solubility changes will greatly benefit from
up-to-date, manually curated, user-friendly, and ML-friendly
databases.
Manual curation is indispensable, as demonstrated by the
teams that had to discard or change the majority of data from
ProTherm (Table 1) due to erroneous values, incorrect or
missing structures and sequences, non-existent substitutions,
and ambiguous experimental conditions. Many other derivative
datasets were not cleaned thoroughly, compromising the
quality of the resulting predictors. However, this does not come
as a surprise, since as an ML developer, one might have neither
enough resources nor proper expertise to check the sources
and validate the quality of experiments for each data point.
Moreover, with the lack of an updatable database to report
inconsistencies and compare dataset overlaps, one has to
repeat the cleaning steps almost from scratch every time before
training a predictor on more recent data. This repetition leads
to a waste of time and delays the maturation of the field into
the next stage of ML development, e.g. in-depth analysis and
interpretation of successful predictors to uncover biophysical
mechanisms behind better predictions.
User-friendliness in terms of graphical summary and
statistics will allow faster monitoring of the structure of the
data to reveal biases in real-time. These refer to over-
represented proteins or protein families, amino acids chosen for
Table 2. Mutational datasets for training predictors of protein solubility change.
Name Data points #
Proteins
Comments Availability[a] Year
OptSolMut[68] 137 in total:
59 increased
78 decreased
19 Binary classification for single- and multiple-point mutants from 15 published studies,
with PDB IDs provided. Among 105 single-point mutants, 61 decreased and 44
increased solubility compared to wild types. In total, 121 mutants were soluble both
before and after the mutation, but the extent of solubility changed. Also 26 mutants
have stability changes reported.
xls table 2010




19 Binary classification for single- and multiple-point mutants from 4 published studies,
with sequences of wild types and mutants provided. Among 40 single-point mutants, 1
decreased and 38 increased solubility compared to wild types.
xls table 2014
Aggrescan3D[70] 129 in total:
87 increased
42 decreased
29 Binary classification for single- and multiple-point mutants from 28 published studies,
with PDB IDs provided. Among 106 single-point mutants, 37 decreased and 69










71 Five-level classification for single-point mutants from >80 published studies using a
multi-step literature search and data mining tools. Mutations affecting aggregation
were excluded due to a different physicochemical phenomenon. Links to wild type
sequences are provided for all proteins, and PDB IDs for 14 proteins. Among 136
mutations decreasing solubility, 46 were classified as decreasing significantly. Among





49 All neutral mutations, as well as ambiguous examples such as those with sequence
mismatches, were deleted from PonSol dataset. Only proteins with a maximum
pairwise sequence identity of <30% with the CamSol dataset were kept. Links to wild
type sequences are provided.
csv table 2017
[a] Data with their assignment to individual datasets will be available in the database SoluProtMutDB: loschmidt.chemi.muni.cz/soluprotmutdb. [b] 142
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mutation or those substituting, locations of the mutations, e.g.
with respect to the sequence, secondary structure elements,
protein surface, tunnels, active sites, etc. The identification of
such biases is of critical importance in ML – a data-driven
strategy unable to correct data biases automatically, without
additional tweaking. The prediction power of an ML-based
model has yet to be explored for the poorly represented
substitutions or proteins with low homology or different
unfolding patterns than those in the training data.
The demand from the ML side also comes for the structure
of such a database. The precise identification of mutations,
corresponding sequences, and PDB IDs is one ingredient.
Another one is adhering to the tidy data principles,[73] i. e. data
representation in a clear table format where columns corre-
spond to variables, such as substitutions, protein identifiers,
experimental conditions, etc., and each row corresponds to
experimental observation. While these principles seem easy to
implement, representing multiple-point mutations or new
experimental setups will challenge the database developers.
An interesting recent initiative is ProtaBank[74] – the data-
base aimed to collect protein engineering data in one place,
including some of the datasets mentioned earlier. The creators
opted to target a wide range of assays, an excellent idea given
the increasing interest in data generation and lack of any
central repository of this kind. They also offered several search
tools to analyze comprehensively published results concerning
a particular sequence inquiry, including related sequences given
by BLAST search. On the other hand, the wide focus and
variability of the supported data types come at the cost of
increasing the effort required for fetching all the available data,
e.g. protein stability or solubility changes, and processing them
into ML-friendly format. With this in mind, we are currently
working on two manually curated ML-oriented mutational
databases to be officially released in 2020: FireProtDB for protein
stability (loschmidt.chemi.muni.cz/fireprotdb) and SoluProt-
MutDB (loschmidt.chemi.muni.cz/soluprotmutdb) for protein sol-
ubility changes. The preliminary versions include ca. 14 000
single-point mutants in around 270 proteins and over 10 000
data points from 100 proteins, respectively. Interestingly, most
of the teams, including ours, have resorted to manual search for
data in literature so far. Thus, automated data mining remains
largely unexplored in this respect.[71,75] The mutational datasets
discussed earlier present significant challenges in this respect
since the information about mutations and their effects is
usually scattered across the publication, and additional effort is
required, e.g., to identify automatically whether a positive value
of ~~G found in a text means increased or decreased stability.
Regarding the perspectives in generating new data, several
recent experimental techniques raise hopes of significantly
enhancing the available data on mutational changes. In
particular, deep mutational scanning[76] that couples next-
generation sequencing[77,78] with high-throughput assays, e.g.
based on fluorescence-activated cell sorting.[79,80] This approach
links genotype to phenotype by synthesizing a large library of
mutant sequences, selecting for expressed phenotypes, and
sequencing the library before and after the selection to quantify
the fitness of each mutant. The screening protocols are being
actively developed to represent fitness from various angles, and
some of them already approximate protein stability and
solubility.[81–83] Two major advantages of this approach are the
data size and distribution. Data sets generated by deep muta-
tional scanning can easily run into thousands or tens of
thousands of mutants, which is terrific news for data-hungry
ML. The library generated often covers the space of possible
mutations quite uniformly, which compares favorably with
more standard low-throughput approaches, in which the
selection of variants is usually skewed towards anticipated best
performers and negative results are sometimes discarded.
Therefore, we expect many new exciting data sets in the near
future, which is likely to open up new opportunities for using
more powerful ML architectures such as artificial neural net-
works. Several recent reviews identified the trend in biocatalyst
design towards using nonlinear ML models compared to
predominantly simple linear predictors in the past.[25,84] And
such a transition will lead to more accurate and generalizable
tools once a sufficient amount of data is available to steer the
flexibility granted by the nonlinear models.
It is also most desirable if the newly collected data are
published according to the FAIR principles[85,86] that are created
to encourage authors to take data sharing, discoverability, and
reuse into account from the outset of preparing their results.
These principles stipulate that data should be identified,
described, and indexed clearly and unequivocally, should use
standard technical and semantic data formats, variables, and
ontologies, and should provide clearly defined access proce-
dures, ideally by automated means. Regarding the application
of those principles to publications with mutational data, the
following guidelines will help promote the collection of high-
quality data sets for training and validating predictors:
* Include and examine protein sequence identifiers, PDB ID’s,
annotations of mutations, etc. in publications. Any inaccura-
cies in reporting propagate into databases, require signifi-
cantly more effort in identifying at later stages, and often
lead to discarding the data. This is an undesirable outcome
for all the parties involved since the data are not reused and
their scientific impact is curtailed.
* Report and upload as much data as possible, even for those
mutations that did not lead to the desired outcome. Detailed
numerical data is often provided only for several mutants out
of all those tested, and the rest are reported in an
aggregated format only, such as on a graph or in a table of
descriptive statistics, precluding their usage in ML training.
* Publish the data as supplements to the original publication,
where they are less likely to be lost. Personal data storages
get closed, group pages move to new locations, and depart-
ments get restructured, which is why many datasets are now
unavailable as their links stopped working.[1]
* Add a csv or xls data table, preferably already in the “tidy”
format, even when some of the values are already reported
in the main text to improve the access to your data, promote
your work among the bioinformatics community, and
increase its impact.
Finally, we would urge companies to release their data sets,
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undesirable disclosure but should be feasible for past results.
The power of ML-based predictors comes from exploiting all
the available data, and while individual gains are not always
apparent, the whole protein engineering community will
benefit from time, effort, and resources saved using predictors
that are more accurate. Data scarcity is now the major bottle-
neck for developing more precise predictors, and if we want to
accelerate the research of human neurodegenerative disorders,
metabolic diseases, cancer, produce more efficient drugs, and
widen the industrial application of biocatalysts, sharing your
data is a small piece of the puzzle that might lead to bigger
improvements.
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